HIV-1 infection and risk of tuberculosis after rifampicin treatment.
Corbett
E L
EL
Mallory
K F
KF
Grant
A D
AD
Churchyard
G J
GJ
De Cock
K M
KM
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D015658:HIV Infections / Q000382:microbiology*; D015497:HIV-1; D006801:Humans; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy* / Q000821:virology
D000904:Antibiotics, Antitubercular; D012293:Rifampin